BFC Planning’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$158K Sell
692
-136
-16% -$34.4K 0.01% 1029
2026
Q2
$221K Buy
828
+30
+4% +$7.01K 0.01% 897
2026
Q1
$183K Hold
798
– – 0.01% 907
2025
Q4
$170K Buy
798
+26
+3% +$5.37K 0.01% 930
2025
Q3
$153K Buy
+772
New +$144K 0.01% 763

Other funds holding ASND

BFC Planning's ASND Position: Q3 2026 in Review

BFC Planning reduced its Ascendis Pharma (ASND) stake by 16% in Q3 2026, selling an estimated $34.4K and leaving 692 shares worth $158K. The position accounts for 0.01% of the portfolio, ranked #1029.

BFC Planning first reported a position in ASND in Q3 2025 and has held it in 5 quarters since. The position peaked at $221K in Q2 2026. 255 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • BFC Planning held 692 shares of Ascendis Pharma worth $158K as of Q3 2026.
  • BFC Planning sold 136 Ascendis Pharma shares in Q3 2026, an estimated $34.4K.
  • Ascendis Pharma made up 0.01% of BFC Planning's portfolio in Q3 2026, its #1029 holding.
  • BFC Planning first reported a position in Ascendis Pharma in Q3 2025 and has held it in 5 quarters since.
  • BFC Planning's Ascendis Pharma position peaked at $221K in Q2 2026.
  • 255 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.